Syndax Pharmaceuticals, Inc.
Syndax Pharmaceuticals, Inc. (SNDX) Stock Forecast & Analyst Price Target
Wall Street consensus, 12-month price targets, model projections, and EPS/revenue estimates — from analyst data and price history.
sndx · stock forecast · 22 analysts (3M) · FMP · updated Jun 8, 2026
Analyst Rating & Consensus
Based on 22 Wall Street analysts in the past 3 months
Buy
22 analysts
consensus
Rating Breakdown
12-Month Price Target
High
$46.00
Consensus
$41.00
+141.7% upside
Low
$37.00
Median: $40 · Last Close: $16.96
12-Month Price Target Forecast
Historical closing prices + analyst 12-month price target forecast cone
Consensus Target
$41.00
141.7% upside
High Target
$46
171.2%
Low Target
$37
118.2%
Current Price
$16.96
as of today
Based on analyst price targets, the SNDX stock price prediction for the next 12 months ranges from $37 to $46. The consensus SNDX price forecast of $41.00 implies 141.7% upside from the current price of $16.96.
Short-Term Price Prediction
Algorithmically generated · Updated daily
| Date | Predicted Price | Change |
|---|---|---|
| 2026-06-09 | $16.11 | ↓ 5.00% |
1-day model range: $16.02–$16.21. Peak: $16.21 (-5.00%).
Long-Term Stock Price Prediction
Annual stock price forecast · 2027 / 2028 / 2029 / 2030 / 2031
| Year | Avg Price | Change |
|---|---|---|
| 2027 | $16 | -5.0% |
| 2028 | $16 | -7.6% |
| 2029 | $15 | -9.0% |
| 2030 | $15 | -9.7% |
| 2031 | — | -10.1% |
Stock Forecast Based on Technical Analysis
14 TA signals (SMA×6 + EMA×6 + RSI + MACD) · EEAT method transparency
Market Sentiment
BEARISH
Based on 14 technical indicators
Refreshes daily from EOD close
Moving Averages · SNDX · Jun 8, 2026
Latest Analyst Ratings & Upgrades
| Date | Brokerage | Action | Rating |
|---|---|---|---|
| 2026-05-22 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2026-05-13 | UBS | Maintains | Buy→Buy |
| 2026-05-01 | Barclays | Maintains | Overweight→Overweight |
| 2026-04-01 | Goldman Sachs | Maintains | Buy→Buy |
| 2026-03-31 | Mizuho | Maintains | Outperform→Outperform |
| 2026-03-09 | JP Morgan | Maintains | Overweight→Overweight |
| 2026-03-02 | Citigroup | Maintains | Buy→Buy |
| 2026-01-27 | Mizuho | Maintains | Outperform→Outperform |
| 2025-12-09 | BTIG | Maintains | Buy→Buy |
| 2025-11-24 | Barclays | Maintains | Overweight→Overweight |
Wall Street analysts have recently issued updated ratings on Syndax Pharmaceuticals, Inc. (SNDX) stock. Of the recent 114 rating actions, 0 were upgrades and 2 were downgrades. 22 analysts currently cover SNDX.
Analyst Recommendation Trends
SNDX analyst recommendation trends show decreasing buy-side sentiment over the past 6 months. Buy rating actions changed from 4 to 3 per month.
Financial Forecast: EPS & Revenue Estimates
Revenue This Year
$345M
↓ 50.2% YoY
Revenue Next Year
$510M
↑ 47.5% YoY
EPS This Year
$-1.79
EPS Next Year
$-0.59
↓ 67.1% YoY
EPS ForecastReported vs Estimated
Analysts forecast SNDX EPS of $-1.79 for the current fiscal year, based on estimates from 9 analysts. The SNDX revenue forecast is $345M for the current year. These are analyst consensus estimates via FMP / S&P Global.
About Forecast & Price Prediction
The SNDX stock forecast is supported by two independent data sources: analyst consensus ratings from 22 Wall Street analysts (S&P Global / FMP), and technical analysis calculated from historical EOD price data. The consensus SNDX price target is $41.00 (+141.7% upside), with an analyst consensus of Buy.
The SNDX short-term stock prediction for tomorrow is $16.11 (-5.00%). The SNDX stock price prediction for 2027 estimates an average of $16. The SNDX stock prediction for 2030 projects a range of $14–$16.
Syndax Pharmaceuticals, Inc. trades on NASDAQ under the ticker SNDX. The SNDX stock outlook for 2027 is broadly positive, supported by a Buy consensus among 91% of covering analysts.
Frequently asked questions
SNDX forecast · 8 questionsAccording to 22 Wall Street analysts, the average 12-month SNDX price target is $41.00, with a high forecast of $46.00 and a low of $37.00. The median price target is shown in the chart above when available. This implies +141.7% potential upside from the current price of $16.96.
· Analyst data: Financial Modeling Prep (FMP) · S&P Global Market Intelligence · Technical analysis: FMP /historical-price-eod/light · Updated: Hourly (analyst) · Daily (technical)
⚠ This information is provided for informational purposes only and does not constitute investment advice. Short-term and long-term price predictions are algorithmically generated and carry significant uncertainty. Past performance does not guarantee future results. Always conduct your own due diligence before making investment decisions.